Dashboard
Manage Tickers

BNTXBioNTech SE

Nasdaq biontech.de


$ 88.43 $ -3.65 (-3.96 %)    

Monday, 17-Jun-2024 15:21:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 486.45 $ 6.49 (1.35 %)
DIA $ 388.85 $ 3.79 (0.98 %)
SPY $ 548.26 $ 6.18 (1.14 %)
TLT $ 93.66 $ -0.20 (-0.21 %)
GLD $ 214.40 $ -0.48 (-0.22 %)
$ 92.08
$ 90.57
$ 86.53 x 1,100
$ 88.54 x 100
$ 87.37 - $ 90.66
$ 85.21 - $ 125.83
768,301
na
21.89M
$ 0.08
$ 0.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-is-pfizer-partner-biontech-stock-trading-lower-on-monday
Why Is Pfizer Partner BioNTech Stock Tradi...
06/17/2024 17:22:46

BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for adva...

biontech-partner-medilink-therapeutics-says-fda-has-placed-partial-clinical-hold-on-phase-1-trial-of-bnt326yl202-for-heavily-pre-treated-advanced-or-metastatic-egfr-mutated-non-small-cell-lung-cancer-or-hrher2-negative-breast-cancer-6k
BioNTech Partner Medilink Therapeutics Say...
06/17/2024 11:27:12

The partial hold affects the enrollment of new patients in the trial in the U.S.  The FDA has shared with MediLink concerns th...

Core News & Articles
FDA On June 13 Updates Advice To Manufactu...
06/14/2024 18:13:02

- Reuters

evaluating-biontech-insights-from-15-financial-analysts
Evaluating BioNTech: Insights From 15 Fina...
06/10/2024 12:00:42

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
06/10/2024 11:08:39

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

moderna-seeks-fda-approval-for-updated-covid-19-shot-for-upcoming-season
Moderna Seeks FDA Approval For Updated COV...
06/07/2024 16:05:42

Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.

Core News & Articles
FDA Advised Manufacturers Of Authorized Co...
06/07/2024 14:47:41

- Reuters

Core News & Articles
Novavax Says FDA Panel Backs Update For Mo...
06/05/2024 20:36:55

- Bloomberg

Core News & Articles
'First-ever human death of bird flu strain...
06/05/2024 20:22:27

https://globalnews.ca/news/10547712/bird-flu-death-mexico-h5n2/#:~:text=It%20started%20on%20April%2017,to%20complications%20of%...

Core News & Articles
FDA Advisers Support Inclusion Of JN1 COVI...
06/05/2024 19:23:35

- Bloomberg

Core News & Articles
FDA Advisers Vote In Favor Of Recommending...
06/05/2024 18:51:23

- Reuters

whats-going-on-with-novavax-stock
What's Going On With Novavax Stock?
06/05/2024 17:21:35

Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look...

Core News & Articles
Pfizer And Partner BioNTech Says Prepared ...
06/05/2024 12:15:08

- Reuters

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
06/04/2024 10:40:32

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

Core News & Articles
WATCH: Dr. Fauci Testifies Live On COVID-1...
06/03/2024 14:49:38

https://www.youtube.com/watch?v=qCsEbq9SpsM 

Core News & Articles
U.S. FDA Staff Says Covid Vaccine Makers S...
06/03/2024 14:03:33

- Reuters - Reuters 

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
06/03/2024 10:31:29

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

Core News & Articles
Genmab, BioNTech Announced Data At ASCO, S...
06/02/2024 15:02:07

Genmab A/S (NASDAQ:GMAB) and BioNTech SE (NASDAQ:BNTX) todayannounced initial data from the Phase 2 GCT1046-04 trial (NCT051172...

watching-biontech-shares-see-volume-to-the-upside-as-traders-circulate-phase-iii-harmoni-2-trial-data-from-summit-therapeutics-may-be-seen-as-favorable-for-biontechs-oncology-pipeline
Watching BioNTech; Shares See Volume To Th...
05/30/2024 19:04:46

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
05/30/2024 11:02:57

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)